Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-002256
Accepted
2025-07-16 00:15:11
Documents
1
Effectiveness Date
2025-07-15

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 604
  Complete submission text file 9999999995-25-002256.txt   1853
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-288120 | Film No.: 251126099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)